Brief: Jacobio Pharmaceuticals Group Says FY Loss RMB1,513.7 Mln
26/03/2021 15:20
March 26 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd
1167.HK :
* FY REVENUE RMB486.3 MILLION
* FY LOSS RMB1,513.7 MILLION VERSUS LOSS RMB425.8 MILLION
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0326/2021032602472.pdf
Further company coverage: 1167.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan